Ost-müük Biodesix, Inc. - BDSX CFD
Lisa lemmikuks- Kokkuvõte
- Ajaloolised andmed
- Sündmused
- Tuluaruanne
- Bilanss
- Rahavood
- Omand
Hinnavahe | 0.0556 | ||||||||
Pika positsiooni ööpäeva tasu
Long position overnight fee
Mine platvormile | -0.024068% | ||||||||
Lühikese positsiooni ööpäeva tasu
Short position overnight fee
Mine platvormile | 0.001846% | ||||||||
Ööpäeva tasu aeg | 21:00 (UTC) | ||||||||
Min kauplemise kogus | 1 | ||||||||
Valuuta | USD | ||||||||
Tagatis | 20% | ||||||||
Aktsiabörs | United States of America | ||||||||
Kauplemise vahendustasu | 0% |
*Information provided by Capital.com
Eelmine sulgemine* | 1.7072 |
Avatud* | 1.6873 |
Aastane muutus* | -7.8% |
Päeva ulatus* | 1.6873 - 1.7372 |
52 nädala ulatus | 0.96-3.00 |
Keskmine maht (10 päeva) | 142.92K |
Keskmine maht (3 kuud) | 2.52M |
Turukapitalisatsioon | 134.90M |
P/E suhtarv | -100.00K |
Ringluses olevad aktsiad | 77.97M |
Tulu | 38.21M |
EPS | -1.60 |
Dividendid (% kasumist) | N/A |
Beeta | -100.00K |
Järgmine tuluaruande kuupäev | May 9, 2023 |
Kõigi andmete allikas on Refinitiv, välja arvatud tärniga märgitud, kus *-ga andmed on esitanud Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Sulgemishind | Change (%) | Avamishind | High | Low |
---|---|---|---|---|---|---|
Mar 28, 2023 | 1.7172 | 0.0100 | 0.59% | 1.7072 | 1.7372 | 1.6473 |
Mar 27, 2023 | 1.7072 | -0.0200 | -1.16% | 1.7272 | 1.7272 | 1.6773 |
Mar 24, 2023 | 1.7073 | 0.0800 | 4.92% | 1.6273 | 1.7073 | 1.6273 |
Mar 23, 2023 | 1.6174 | -0.2596 | -13.83% | 1.8770 | 1.8770 | 1.6074 |
Mar 22, 2023 | 1.8570 | 0.0799 | 4.50% | 1.7771 | 1.8969 | 1.7472 |
Mar 21, 2023 | 1.7771 | 0.0300 | 1.72% | 1.7471 | 1.7871 | 1.7372 |
Mar 20, 2023 | 1.7172 | -0.0399 | -2.27% | 1.7571 | 1.7771 | 1.6173 |
Mar 17, 2023 | 1.7571 | -0.0300 | -1.68% | 1.7871 | 1.8670 | 1.7472 |
Mar 16, 2023 | 1.7871 | -0.0799 | -4.28% | 1.8670 | 1.9070 | 1.7172 |
Mar 15, 2023 | 1.8770 | 0.2896 | 18.24% | 1.5874 | 1.8870 | 1.5874 |
Mar 14, 2023 | 1.6373 | -0.0100 | -0.61% | 1.6473 | 1.6973 | 1.6274 |
Mar 13, 2023 | 1.6473 | 0.1498 | 10.00% | 1.4975 | 1.7172 | 1.4975 |
Mar 10, 2023 | 1.5675 | 0.1398 | 9.79% | 1.4277 | 1.6573 | 1.3877 |
Mar 9, 2023 | 1.4776 | -0.2096 | -12.42% | 1.6872 | 1.6873 | 1.4676 |
Mar 8, 2023 | 1.6673 | -0.0898 | -5.11% | 1.7571 | 1.7971 | 1.6673 |
Mar 7, 2023 | 1.7771 | 0.0599 | 3.49% | 1.7172 | 1.7971 | 1.7172 |
Mar 6, 2023 | 1.7572 | -0.3194 | -15.38% | 2.0766 | 2.1366 | 1.7172 |
Mar 3, 2023 | 1.9668 | 0.0000 | 0.00% | 1.9668 | 2.0467 | 1.9668 |
Mar 2, 2023 | 1.9668 | -0.0300 | -1.50% | 1.9968 | 2.0368 | 1.9569 |
Mar 1, 2023 | 1.9868 | -0.0399 | -1.97% | 2.0267 | 2.0467 | 1.9369 |
Biodesix, Inc. Events
Kellaaeg (UTC) (UTC) | Riik | Sündmus |
---|---|---|
No events scheduled |
- Aastas
- Kvartalis
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Kogutulu | 38.212 | 54.506 | 45.557 | 24.552 | 20.432 |
Tulu | 38.212 | 54.506 | 45.557 | 24.552 | 20.432 |
Kulud, Kokku | 14.154 | 30.518 | 21.998 | 6.074 | 4.406 |
Brutokasum | 24.058 | 23.988 | 23.559 | 18.478 | 16.026 |
Kogu tegevuskulu | 95.78 | 93.148 | 68.491 | 51.293 | 44.095 |
Müük/Üldine/admin kulud, kokku | 58.458 | 47.958 | 32.328 | 30.637 | 25.899 |
Uuringud ja arendus | 13.102 | 12.789 | 10.818 | 10.468 | 8.188 |
Ootamatud kulutused (tulu) | 7.062 | -2.298 | 3.451 | 1.739 | |
Other Operating Expenses, Total | 0 | 1.622 | 0.818 | 0.663 | 3.863 |
Tulud majandustegevusest | -57.568 | -38.642 | -22.934 | -26.741 | -23.663 |
Intressitulud (kulu), muud tulud, neto | -8.072 | -4.508 | -7.586 | -2.953 | -2.892 |
Muud, neto | 0.193 | -0.009 | -0.83 | -1.032 | 0.389 |
Netotulu enne makse | -65.447 | -43.159 | -31.35 | -30.726 | -26.166 |
Netotulu pärast makse | -65.447 | -43.159 | -31.35 | -30.726 | -26.166 |
Netotulu enne erikulusid | -65.447 | -43.159 | -31.35 | -30.726 | -26.166 |
Netotulu | -65.447 | -43.159 | -31.35 | -30.726 | -26.166 |
Arvestatav tulu, v a erikulud | -65.447 | -43.159 | -31.35 | -30.726 | -26.166 |
Arvestatav tulu, koos erikuludega | -65.447 | -43.159 | -31.35 | -30.726 | -26.166 |
Jaotamisele kuuluv netotulu | -65.447 | -43.159 | -31.35 | -30.726 | -26.166 |
Keskmine jaotamisele kuuluv aktsia kohta | 42.103 | 27.365 | 26.5615 | 26.2541 | 26.2541 |
Jaotatav EPS, v a erakorralised kulud | -1.55445 | -1.57716 | -1.18028 | -1.17033 | -0.99665 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | |||
Jaotamisele kuuluv normaal-EPS | -1.38672 | -1.66114 | -1.14948 | -1.03889 | -0.93041 |
Depreciation / Amortization | 3.004 | 2.559 | 2.529 |
Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | |
---|---|---|---|---|---|
Kogutulu | 9.607 | 11.107 | 10.95 | 6.548 | 7.224 |
Tulu | 9.607 | 11.107 | 10.95 | 6.548 | 7.224 |
Kulud, Kokku | 3.306 | 3.633 | 3.98 | 3.235 | 2.493 |
Brutokasum | 6.301 | 7.474 | 6.97 | 3.313 | 4.731 |
Kogu tegevuskulu | 27.474 | 21.769 | 25.528 | 21.009 | 19 |
Müük/Üldine/admin kulud, kokku | 16.626 | 15.114 | 15.235 | 14.487 | 13.558 |
Uuringud ja arendus | 3.565 | 2.97 | 3.361 | 3.206 | 2.852 |
Ootamatud kulutused (tulu) | 3.977 | 0.052 | 2.952 | 0.081 | 0.097 |
Tulud majandustegevusest | -17.867 | -10.662 | -14.578 | -14.461 | -11.776 |
Intressitulud (kulu), muud tulud, neto | -2.55 | -3.039 | -1.346 | -1.137 | -1.496 |
Muud, neto | 0.079 | 0.002 | 0.1 | 0.012 | -0.01 |
Netotulu enne makse | -20.338 | -13.699 | -15.824 | -15.586 | -13.282 |
Netotulu pärast makse | -20.338 | -13.699 | -15.824 | -15.586 | -13.282 |
Netotulu enne erikulusid | -20.338 | -13.699 | -15.824 | -15.586 | -13.282 |
Netotulu | -20.338 | -13.699 | -15.824 | -15.586 | -13.282 |
Arvestatav tulu, v a erikulud | -20.338 | -13.699 | -15.824 | -15.586 | -13.282 |
Arvestatav tulu, koos erikuludega | -20.338 | -13.699 | -15.824 | -15.586 | -13.282 |
Jaotamisele kuuluv netotulu | -20.338 | -13.699 | -15.824 | -15.586 | -13.282 |
Keskmine jaotamisele kuuluv aktsia kohta | 57.553 | 40.448 | 39.239 | 31.07 | 27.059 |
Jaotatav EPS, v a erakorralised kulud | -0.35338 | -0.33868 | -0.40327 | -0.50164 | -0.49085 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | ||
Jaotamisele kuuluv normaal-EPS | -0.28428 | -0.3374 | -0.32804 | -0.49903 | -0.48727 |
Other Operating Expenses, Total | 0 | 0 | 0 | 0 | 0 |
- Aastas
- Kvartalis
2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|
Käibevarad kokku | 43.613 | 86.14 | 12.7 | 9.913 |
Raha ja lühiajalised investeeringud | 32.712 | 62.126 | 5.286 | 5.914 |
Raha ja ekvivalendid | 32.712 | 62.126 | 5.286 | 5.914 |
Laekumata arved, neto | 3.656 | 15.304 | 5.292 | 1.892 |
Accounts Receivable - Trade, Net | 3.656 | 15.304 | 5.292 | 1.892 |
Other Current Assets, Total | 7.245 | 8.71 | 2.122 | 2.107 |
Total Assets | 76.097 | 121.07 | 41.633 | 39.057 |
Property/Plant/Equipment, Total - Net | 4.179 | 3.178 | 2.12 | 1.388 |
Property/Plant/Equipment, Total - Gross | 10.928 | 9.902 | 8.506 | 6.956 |
Accumulated Depreciation, Total | -6.749 | -6.724 | -6.386 | -5.568 |
Goodwill, Net | 15.031 | 15.031 | 11.631 | 10.804 |
Intangibles, Net | 11.617 | 13.26 | 15.092 | 16.852 |
Other Long Term Assets, Total | 1.657 | 3.461 | 0.09 | 0.1 |
Total Current Liabilities | 28.96 | 32.125 | 22.6 | 4.468 |
Accounts Payable | 1.662 | 8.964 | 1.717 | 0.886 |
Accrued Expenses | 4.899 | 4.69 | 1.899 | 1.568 |
Notes Payable/Short Term Debt | 0 | 0 | 12.045 | 0 |
Other Current Liabilities, Total | 22.38 | 6.631 | 6.939 | 2.014 |
Total Liabilities | 56.37 | 79.904 | 76.213 | 53.125 |
Total Long Term Debt | 9.993 | 15.926 | 23.812 | 23.099 |
Long Term Debt | 9.993 | 15.926 | 23.812 | 23.099 |
Other Liabilities, Total | 17.417 | 31.853 | 29.801 | 25.558 |
Total Equity | 19.727 | 41.166 | -34.58 | -14.068 |
Redeemable Preferred Stock | 0 | 0 | 193.959 | 183.962 |
Common Stock | 0.031 | 0.027 | 0.001 | 0.001 |
Additional Paid-In Capital | 321.669 | 299.953 | 2.324 | 2.107 |
Retained Earnings (Accumulated Deficit) | -301.973 | -258.814 | -230.864 | -200.138 |
Total Liabilities & Shareholders’ Equity | 76.097 | 121.07 | 41.633 | 39.057 |
Total Common Shares Outstanding | 30.7896 | 26.5615 | 26.2541 | 26.2541 |
Current Port. of LT Debt/Capital Leases | 0.019 | 11.84 | 0 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Käibevarad kokku | 27.233 | 43.613 | 56.445 | 68.45 | 81.244 |
Raha ja lühiajalised investeeringud | 16.427 | 32.712 | 47.913 | 56.349 | 55.329 |
Raha ja ekvivalendid | 16.427 | 32.712 | 47.913 | 56.349 | 55.329 |
Laekumata arved, neto | 3.774 | 3.656 | 2.784 | 5.281 | 18.367 |
Accounts Receivable - Trade, Net | 3.774 | 3.656 | 2.784 | 5.281 | 18.367 |
Other Current Assets, Total | 7.032 | 7.245 | 5.748 | 6.82 | 7.548 |
Total Assets | 61.651 | 76.097 | 89.997 | 101.804 | 115.486 |
Property/Plant/Equipment, Total - Net | 6.247 | 4.179 | 4.432 | 3.378 | 3.387 |
Property/Plant/Equipment, Total - Gross | 13.409 | 10.928 | 11.827 | 10.471 | 10.369 |
Accumulated Depreciation, Total | -7.162 | -6.749 | -7.395 | -7.093 | -6.982 |
Goodwill, Net | 15.031 | 15.031 | 15.031 | 15.031 | 15.031 |
Intangibles, Net | 11.131 | 11.617 | 11.992 | 12.4 | 12.821 |
Other Long Term Assets, Total | 2.009 | 1.657 | 2.097 | 2.545 | 3.003 |
Total Current Liabilities | 29.811 | 28.96 | 22.787 | 21.272 | 16.124 |
Accounts Payable | 2.12 | 1.662 | 1.6 | 1.16 | 3.747 |
Accrued Expenses | 4.597 | 4.899 | 3.533 | 2.959 | 2.622 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 0.051 | 0.019 | 0.02 | 3.106 | 2.707 |
Other Current Liabilities, Total | 23.043 | 22.38 | 17.634 | 14.047 | 7.048 |
Total Liabilities | 53.87 | 56.37 | 73.964 | 76.031 | 79.054 |
Total Long Term Debt | 10.055 | 9.993 | 29.975 | 29.955 | 30.328 |
Long Term Debt | 10.055 | 9.993 | 29.975 | 29.955 | 30.328 |
Other Liabilities, Total | 14.004 | 17.417 | 21.202 | 24.804 | 32.602 |
Total Equity | 7.781 | 19.727 | 16.033 | 25.773 | 36.432 |
Redeemable Preferred Stock | 0 | 0 | 0 | 0 | |
Common Stock | 0.032 | 0.031 | 0.027 | 0.027 | 0.027 |
Additional Paid-In Capital | 325.308 | 321.669 | 304.697 | 302.923 | 302.18 |
Retained Earnings (Accumulated Deficit) | -317.559 | -301.973 | -288.691 | -277.177 | -265.775 |
Total Liabilities & Shareholders’ Equity | 61.651 | 76.097 | 89.997 | 101.804 | 115.486 |
Total Common Shares Outstanding | 31.8893 | 30.7896 | 27.0201 | 26.9489 | 26.7854 |
- Aastas
- Kvartalis
2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|
Netotulu/algväärtus | -43.159 | -31.35 | -30.726 | -26.166 |
Raha majandustegevusest | -28.223 | -21.366 | -21.726 | -17.677 |
Raha majandustegevusest | 3.178 | 2.903 | 2.793 | 1.74 |
Mittelikviidsed varad | 7.167 | 11.882 | 7.852 | 6.496 |
Muutused tööjõus | 4.591 | -4.801 | -1.645 | 0.253 |
Tulu investeeringutelt | -2.547 | -2.927 | -1.872 | -0.617 |
Kapitalikulutused | -2.547 | -2.177 | -1.416 | -0.617 |
Muud rahavood investeeringutelt, kokku | 0 | -0.75 | -0.456 | 0 |
Rahavood investeeringutelt | 1.262 | 81.131 | 22.972 | 19.032 |
Rahavoogudesse investeerimine | -0.5 | -8.249 | -0.119 | -0.283 |
Aktsiate emiteerimine (tagasiost), neto | 17.112 | 73.34 | 10.047 | 8.55 |
Laenu väljastamine (kustutamine), neto | -15.35 | 16.04 | 13.044 | 10.765 |
Rahaline kogumuutus | -29.508 | 56.838 | -0.626 | 0.738 |
Makstud intressid | 1.676 | 1.844 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Net income/Starting Line | -15.586 | -43.159 | -29.877 | -18.363 | -6.961 |
Cash From Operating Activities | -13.099 | -28.223 | -18.026 | -10.236 | -11.326 |
Cash From Operating Activities | 0.908 | 3.178 | 2.323 | 1.523 | 0.746 |
Non-Cash Items | 2.674 | 7.167 | 4.704 | 5.336 | 3.721 |
Changes in Working Capital | -1.095 | 4.591 | 4.824 | 1.268 | -8.832 |
Cash From Investing Activities | -0.352 | -2.547 | -1.906 | -0.864 | -0.516 |
Capital Expenditures | -0.352 | -2.547 | -1.906 | -0.864 | -0.516 |
Other Investing Cash Flow Items, Total | 0 | 0 | 0 | 0 | |
Cash From Financing Activities | -2.834 | 1.262 | 5.625 | 5.229 | 4.951 |
Financing Cash Flow Items | -4.6 | -0.5 | 0.232 | -0.109 | -0.108 |
Issuance (Retirement) of Stock, Net | 1.674 | 17.112 | 0.739 | 0.679 | 0.475 |
Issuance (Retirement) of Debt, Net | 0.092 | -15.35 | 4.654 | 4.659 | 4.584 |
Net Change in Cash | -16.285 | -29.508 | -14.307 | -5.871 | -6.891 |
Cash Interest Paid | 0.223 |
Investori nimi | Investori liik | Ringluse protsent | Hoitud osakud | Muutus osakutes | Hoidmise kuupäev | Hinnang käibele |
---|---|---|---|---|---|---|
Schuler (Jack W) | Individual Investor | 25.5879 | 19952112 | 8695652 | 2022-11-21 | |
Kennedy (Lawrence T Jr.) | Individual Investor | 19.0156 | 14827404 | 0 | 2023-01-03 | MED |
Patience (John) | Individual Investor | 9.0025 | 7019695 | 1739130 | 2022-11-21 | LOW |
Birchview Capital, LP | Investment Advisor | 6.4632 | 5039633 | 2884624 | 2022-12-31 | LOW |
AIGH Capital Management, LLC. | Private Equity | 5.8936 | 4595512 | -973389 | 2022-12-31 | MED |
Cawthorn (Robert E) | Individual Investor | 4.6838 | 3652220 | 1723341 | 2022-11-21 | LOW |
Strobeck (Matthew W) | Individual Investor | 3.7251 | 2904668 | 1304345 | 2022-11-21 | LOW |
Industrial Development Funding LLC | Corporation | 2.432 | 1896374 | 0 | 2022-03-01 | LOW |
Worth Venture Partners, LLC | Investment Advisor/Hedge Fund | 1.9211 | 1497963 | 1497963 | 2022-12-31 | HIGH |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 1.4189 | 1106403 | 866747 | 2022-12-31 | LOW |
Wells Fargo Advisors | Research Firm | 0.9923 | 773725 | 5000 | 2022-12-31 | LOW |
Essex Investment Management Company, LLC | Investment Advisor/Hedge Fund | 0.4848 | 377994 | -29 | 2022-12-31 | LOW |
Life Sciences Alternative Financing, L.L.C. | Corporation | 0.3771 | 294053 | 0 | 2022-03-01 | LOW |
Cannell & Co. | Investment Advisor | 0.2637 | 205605 | 0 | 2022-12-31 | LOW |
Hutton Scott | Individual Investor | 0.2561 | 199726 | 28499 | 2023-02-09 | HIGH |
Massarany (Hany) | Individual Investor | 0.1769 | 137934 | 130434 | 2022-11-21 | HIGH |
Hightower Advisors, LLC | Investment Advisor | 0.175 | 136434 | 136434 | 2022-12-31 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.1617 | 126122 | 2052 | 2022-12-31 | LOW |
Endurant Capital Management LP | Hedge Fund | 0.1596 | 124430 | -5706 | 2022-12-31 | HIGH |
Millennium Management LLC | Hedge Fund | 0.1382 | 107788 | -10260 | 2022-12-31 | HIGH |
Miks valida Capital.com? Meie numbrid räägivad iseenda eest.
Capital.com Group500K+
Kauplejad
92K+
Igakuiste aktiivsete klientide arv
$53M+
Igakuine investeerimise maht
$30M+
Igakuiselt välja võetud
Kauplemiskalkulaator
Arvutage oma hüpoteetiline võit/kaotus, kui oleksite avanud CFD-tehingu ühel kindlal kuupäeval (valige kuupäev) ja sulgenud teisel kuupäeval (valige kuupäev).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Biodesix, Inc. Company profile
Ettevõttest Biodesix, Inc.
Biodesix, Inc. on Ameerika Ühendriikides asuv ettevõte, mis tegeleb verepõhiste diagnostiliste testide väljatöötamise ja turustamisega onkoloogia jaoks. Ettevõtte toode Biodesix Lung Reflex integreerib genoomilised ja proteoomilised verepõhised tulemused, et avastada kopsuvähi mõlemad küljed. GeneStrat test pakub verepõhiseid mutatsioonitulemusi 72 tunni jooksul mitteväikerakk-kopsuvähiga (NSCLC) patsientidele. VeriStrat test pakub verepõhist ennustavat ja prognostilist proteoomilist teavet (NSCLC) patsientide puhul, kelle test on negatiivne hinnangulise glomerulaarfiltratsiooni kiiruse (EGFR) mutatsioonide suhtes (EGFR metsikut tüüpi) või kelle EGFR-mutatsiooni staatus on teadmata.
Industry: | Medical & Diagnostic Laboratories |
Suite 100
2970 Wilderness Place
BOULDER
COLORADO 80301
US
Tuluaruanne
- Annual
- Quarterly
Teised on vaadanud veel
Kas otsite jätkuvalt vahendajat, keda saab usaldada?
Ühinege 500,000+ kauplejaga üle kogu maailma, kes valisid kauplemiseks veebisaidi Capital.com